Lean line. Same floor. 41% more parts.
A medical-device customer was running out of capacity on a Class II implant component. Buying a building was on the table. We rebuilt the cell instead.
Customer
Mid-cap medical-device OEM, FDA Class II
Engagement
18 months, phased — no production downtime
Team
3 engineers, 1 lean lead, the cell’s own operators
Outcome
41% throughput lift, $0 capex above original budget, zero scrap-rate regression
The honest version of an 18-month rebuild.
0%
Throughput lift
0%
Final OEE
From 62%
0%
First-pass yield
Held throughout
0M
Avoided capex
Building + duplicate cell